Anadis enters US arena for colostrum-derived products

By Laura Crowley

- Last updated on GMT

Related tags: Immune system

Australian firm Anadis has formed a partnership with Garden State
Nutritionals (GSN) having identified potential in America for
colostrum bioactive products for gastro intestinal problems.

Colostrum is the first milk produced by mammals in the late stages of pregnancy and the few days after giving birth. It is high in carbohydrates, protein and antibodies, and low in fat. Yesterday, biopharmaceutical company Anadis announced its new collaboration with GSN, a division of VitaQuest International based in New Jersey that works with dietary supplements. The two companies intend to introduce a range of products based on Anadis' proprietary milk-derived bioactives and immunoglobulins (antibodies). "The combination of GSN's skills with our decade of R&D in the field of dairy-derived colostrum bioactives will now allow Anadis to rapidly penetrate theUSvitamins and dietary supplements market,"​ said Oren Fuerst, vice president for business development at Anadis in New York. Planned launches ​The partnership is looking to release products that relieve symptoms associated with gastro intestinal problems, such as Irritable Bowel Syndrome and Inflammatory Bowel Disease - maladies, Anadis said, that are suffered by 20 percent of the general population. Other areas they hope to enter with its colostrum-based products include the cold and flu market. Fuerst said: In addition, there is a wealth of other opportunities such as in the Athletes and body building market. Overall, we are looking to address some of the largest segments."​ Although the market for products based on colostrum is relatively small according to Anadis, it said its methodology provides a high potency for a broad range of problems. The company claimed that with its proprietary, all-natural colostrum platform, the company can obtain much higher levels of immunoglobulin than alternatives in the market. Fuerst explained to NutraIngredients-USA.com: "This relates to a unique and patented technology for harvesting the colostrum and also to unique vaccines we immunize the cows with in their last trimester of pregnancy, to ensure high level of immunoglobulin and other bioactives in the colostrum that are addressing the target of interest." ​ They focus on every step, from injection of the cows through to harvesting the colostrum and utilizing it in products. GSN ​ GSN is a large custom contract manufacturer of nutritional supplements in the US, producing more than $1bn worth of finished retail products per year to more than 35 countries worldwide. The two companies would not disclose the terms of their agreement or for how long it would last. Jon Weisgal, vice president of marketing at VitaQuest, said: "We are thrilled to have Anadis with its proprietary Colostrum derived bioactives working with us. We see great potential in introducing Anadis to our more than 300 clients." ​The value of the US vitamins and dietary supplements market exceeds $15bn, and experiences a growth rate in excess of 5 percent according to 2007 Euromonitor figures.

Related topics: Dairy-based ingredients

Related news

Related products

show more

Growing Up Bioactives

Growing Up Bioactives

Glanbia Nutritionals | 13-Sep-2022 | Business Advice

Parents are prioritizing their children’s health and wellness with 66% indicating they give their child nutritional supplements once a day*. Support their...

Opportunity Alert: Mobility Matters to your Consumers

Opportunity Alert: Mobility Matters to your Consumers

NZMP (Ingredients by Fonterra) | 16-Aug-2022 | Infographic

The World Health Organization says mobility is critical for healthy ageing, as it’s a core concern seniors face. With mobility’s significant impact on...

Consumers are ditching diets for intuitive eating.

Consumers are ditching diets for intuitive eating.

Fonterra | 02-Aug-2022 | Technical / White Paper

Interest in intuitive eating is reportedly gaining as much traction with consumers as the ketogenic diet. However, without similarly strict macronutrient...

Fonterra Keeps Your Ingredients Ahead of the Curve

Fonterra Keeps Your Ingredients Ahead of the Curve

Fonterra | 26-Jul-2022 | Technical / White Paper

With health and environmental concerns in mind, consumers’ commitment to purchasing organic products continues to grow. Whether your brand is starting...

Related suppliers

Follow us

Products

View more

Webinars